See our blogposts on the EBV-MS project!
In recent years, scientific evidence linking the Epstein-Barr virus (EBV) to the development of Multiple Sclerosis (MS) has grown significantly. EBV, a common herpesvirus that infects most people at some point in their lives, is best known for causing infectious mononucleosis ("mono"). However,...
Managing research data efficiently is crucial for ensuring reproducibility, collaboration, and long-term impact. The EBV-MS project incorporates a large amount of pre-existing data, new experimental data, clinical trials, large-scale genomics and AI-driven analyses across varied data sources. And of...
On November 25th and 26th, the picturesque city of Rome played host to the Annual Consortium Meeting of the EBV-MS Project, where experts from across Europe and the USA gathered to discuss the progress of our groundbreaking research into the link between Epstein-Barr virus (EBV) and Multiple...
From September 18th to 20th, 2024, members of the EBV-MS consortium participated in the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), the world鈥檚 largest MS congress, held in Copenhagen, Denmark. ECTRIMS, Europe鈥檚 leading MS organization, attracts experts globally to...
On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for a pivotal consultation. The objective of this meeting was to ensure meaningful engagement and involvement of expert patients in the ongoing EBV-MS clinical trials, specifically...
On May 30th, the Karolinska Institutet Neuroimmunology Multiple Sclerosis Centre (KNIMS) hosted a symposium entitled "How Current Research Shapes the Future of MS Care." The event brought together 70 participants, including researchers, clinicians, patient advocates, and people living with MS, to...
